Soft Tissue Regeneration Raises Series C Financing, Rebrands as Biorez

Soft Tissue Regeneration closed a US $1.5MM Series C Financing and rebranded as Biorez.

At the 2017 AAOS meeting, the company is attending private meetings to share results of a 15-patient safety study that began in 2Q13. Biorez is the first company to clinically investigate a tissue-engineered scaffold for...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us